Calciphylaxis Treatment Market to Find Better Growth with US$ 2,400 Million By 2026 | CAGR: 9.6%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Calciphylaxis Treatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen Therapy), By End User (Hospital and Clinics, Homecare, and Ambulatory Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,097.7 million in 2017 and is projected to exhibit a CAGR of 9.6% over the forecast period (2018 – 2026).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2251
Calciphylaxis is a serious and uncommon disease in which calcium accumulates in small blood vessels of skin and fat tissues. As a result of this accumulation, blood clots form along with painful skin ulcers and may cause infection that can lead to death. Diagnosis of calciphylaxis is symptoms-based and various tests such as skin biopsy, blood tests, and imaging studies confirm the condition. Although there is no specific treatment available for calciphylaxis, healthcare professionals often lay emphasis on balancing the minerals in the body such as calcium and phosphate that may aid in treatment of the disease. This can be achieved by changing dialysis regimes, medications, or considering surgery for parathyroid glands. Major surgical treatments such as parathyroidectomy are mostly recommended for patients with known primary hyperparathyroidism. However, surgical debridement to remove necrotic tissue and healing of healthy tissue is more widely used, with its efficacy is debated. Doctors also focus on pain control, good nutrition, and excellent ulcer care in case the skin has broken down. Wound management therapies for calciphylaxis include, nonsurgical wound cleansing and Hyperbaric Oxygen Therapy (HBOT). HBOT can be considered as a second line of treatment incase wounds do not improve.
Key players in the market are focused on research and development activities, in order to innovate efficient solution for calciphylaxis. According to the Journal of the American Society of Nephrology 2017 study, Vitamin K deficiency can have a role in development of calciphylaxis. Moreover, according a study published in 2017 by BioMed Central Nephology Journal, four week supplementation of Vitamin K2 can significantly improve vascular calcification.
Browse 24 Market Data Tables and 21 Figures spread through 165 Pages and in-depth TOC on “Calciphylaxis Treatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen Therapy), by End User (Hospital and Clinics, Homecare, and Ambulatory Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026″
To know the latest trends and insights related to calciphylaxis treatment market Press Release, click the link below: https://bit.ly/3gMPI2Q
Key Takeaways of the Global Calciphylaxis Treatment Market:
- The global calciphylaxis treatment market is expected to register a CAGR of 9.6% during the forecast period, owing to increasing cases of calciphylaxis associated with dialysis. According to the Nephrology Dialysis Transplantation Journal 2017 study, the German Calciphylaxis Registry recorded calciphylaxis reporting rate of approximately 30 new cases per year among the dialysis patients between 2006 to 2015
- Among region, North America is expected to witness a lucrative growth in the global calciphylaxis treatment market during the forecast period. This is owing to increasing demand for kidney transplantation procedures and rising number of dialysis patients. According to the National Kidney Foundation, in 2016, around 3,000 patients every month underwent kidney transplant in the U.S.
- Major players operating in the global calciphylaxis treatment market include, 3M, Amgen Inc., BSN Medical, ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris Sanifit S.L.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2251
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire